glutamic acid and Leukemia, Myeloid, Acute

glutamic acid has been researched along with Leukemia, Myeloid, Acute in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, X; Liu, F; Rong, D; Tong, X; Wang, H; Xu, L1
D'Alessandro, A; DeGregori, J; Gregory, MA; Hansen, KC; Nemkov, T; Reisz, JA; Zaberezhnyy, V1
Baran, N; Cai, T; Chan, SM; Davis, RE; DiNardo, C; Flores, ER; Gonzalez, D; Haferlach, T; Jacamo, R; Konoplev, S; Konopleva, M; Li, W; Lodi, A; Ma, H; Majeti, R; Matre, P; Qi, Y; Samudio, I; Schimmer, AD; Su, X; Sweeney, SR; Tiziani, S; Velez, J; Wang, T1
Kaberlein, JJ; Luo, RT; Polak, PE; Simone, F; Thirman, MJ1
Jing, N; Shao, H; Tweardy, DJ; Xu, X1

Other Studies

5 other study(ies) available for glutamic acid and Leukemia, Myeloid, Acute

ArticleYear
Decitabine Enhances Acute Myeloid Leukemia Cell Apoptosis through SH3BGRL Upregulation.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:12

    Topics: Apoptosis; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Glutamic Acid; Humans; Leukemia, Myeloid, Acute; Proteins; RNA, Messenger; U937 Cells; Up-Regulation

2022
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
    Experimental hematology, 2018, Volume: 58

    Topics: Animals; Benzeneacetamides; Benzothiazoles; Cell Line, Tumor; Female; fms-Like Tyrosine Kinase 3; Glutamic Acid; Glutaminase; Glutamine; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, Transgenic; Phenylurea Compounds; Thiadiazoles; Xenograft Model Antitumor Assays

2018
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
    Oncotarget, 2016, Nov-29, Volume: 7, Issue:48

    Topics: Antineoplastic Agents; Apoptosis; Benzeneacetamides; Cell Differentiation; Cell Proliferation; Energy Metabolism; Enzyme Inhibitors; Glutamate Dehydrogenase; Glutamic Acid; Glutaminase; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mutation; Protein Isoforms; Sulfides; Thiadiazoles

2016
ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
    Blood, 2003, Mar-15, Volume: 101, Issue:6

    Topics: Amino Acid Sequence; Animals; Aspartic Acid; Binding Sites; Blotting, Northern; Bone Marrow; Cell Nucleus; Cell Transformation, Neoplastic; Conserved Sequence; DNA-Binding Proteins; Glutamic Acid; HeLa Cells; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Humans; Immunosorbent Techniques; Leukemia, Myeloid, Acute; Mice; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Oncogene Proteins, Fusion; Peptide Fragments; Proto-Oncogenes; Recombinant Fusion Proteins; Retroviridae; Sequence Homology; Serine; Transcription Factors; Transcriptional Elongation Factors; Transfection

2003
Unique structural determinants for Stat3 recruitment and activation by the granulocyte colony-stimulating factor receptor at phosphotyrosine ligands 704 and 744.
    Journal of immunology (Baltimore, Md. : 1950), 2006, Mar-01, Volume: 176, Issue:5

    Topics: Arginine; Cell Line; Computational Biology; Glutamic Acid; Humans; Leukemia, Myeloid, Acute; Ligands; Lysine; Models, Molecular; Phosphopeptides; Phosphotyrosine; Protein Binding; Receptors, Granulocyte Colony-Stimulating Factor; STAT3 Transcription Factor

2006